ecr logo

The next young/early career researcher conference organised by UK charity Invest in ME Research and the European ME Research Group (EMERG) takes place on 2nd June 2023 at the Wellcome Genome Campus near Cambridge, UK, in parallel with the 15th Invest in ME Research International ME Conference.
This will be the first in person young/ecr conference since the pandemic paused events in 2020.
It coincides with the restart of the EMERG ecr initiative - Young EMERG - bringing together early career researchers in Europe to collaborate on research into ME.
The intent is to continue the work that was started with the Thinking the Future conferences that had to be paused in 2020 due to the pandemic.

Apart from reestablishing the European network of young researchers we hope to create a broader network across the continent. which will, in turn, facilitate further international collaboration in research into ME and encourage new ideas to be formulated.

The conference will bring together young international scientists and students working on, or interested in, myalgic encephalomyelitis (and also those involved with long covid research) and will again advance research into the disease by facilitating the sharing of knowledge and collaboration between researchers from around the world.

The event presents a unique networking opportunity for early career researchers involved with research into ME, and those involved in other research areas who would like to collaborate and share knowledge, and those wishing to join the EMERG ecr network.


The workshop programme is subject to change -

Time Topic Speaker/Detail
09:00 Opening Welcome
09:10 Young EMERG and introductions Dr Katharine Seton, Quadram Institute, UK
09:30 Keynote Speaker Dr Daniel Peterson, Simmaron Research, USA
10:00 - 11:30 Metabolic impact of activated HERVs and associated innate immune response in severe ME: towards disease modeling Karen Gimenez, Catholic University of Valencia, Spain
Profiling of the human gut DNA virome in severe ME/CFS Dr Ernie Hsieh, Quadram Instiute, UK
Immunogenetics studies in ME/CFS Dr Riad Hajdarevic, Oslo University Hospital, Norway
Intermittent Hypoxic Treatment as a Novel Therapy in Myalgic Encephalomyelitis Sophie Kjerstein, Aarhus University Hospital, Denmark
Light therapy - a possible treatment for ME? Dr Katharine Seton, Quadram Institute, UK
TBC Rik Haagmans, Quadram Institute, UK
Identifying pathogenic cell phenotypes in cerebrospinal fluid and blood to reveal the underlying biology of complex neuro-immunological diseases Donia Jamal Ramadan, Oslo University Hospital, Norway
11:30 Refreshments
12:00 Overlapping illnesses Chair: TBC
12:00 - 13:00 Immune contribution to fibromyalgia Dr Margot Maurer, Kings College London, UK
Genetic determinants of ME/CFS and dysautonomia Anniina Maria Tervi, University of Helsinki, Finland
TBC Haoyue Sun, Kings College London, UK
Neutrophil dysfunction in long COVID Peter Smith, University of Birmingham, UK
Testing for an autoimmune basis for neurological symptoms in long covid Hayate Javed, Kings College London, UK
13:00 Lunch Research funding opportunities Chair: TBC
14:00 European Research Council Dr. Luis Mendes
14:40 National Institutes of Health (NIH), USA Dr. Vicky Whittemore
15:20 Refreshments ME research and related diseases in the US and Australia Chair: TBC
15:50 - 16:30 What are they loaded with? Protein content of extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome following exercise Katie Glas, Cornell University, USA
TBC Dr Brent L. Williams, Columbia University, USA
Multi-modal MRI to study brain dysfunction in ME/CFS and long COVID Kiran Thapaliya, Griffith University, Australia
Understanding the Behavioral Features of Fatigue in Long COVID Agostina Casamento Moran, John Hopkins University, USA Networking session Chair: TBC
16:30 Breakout groups
17:00 Round table discussion
17:25 Summary
17:30 Adjorn
18:00 Young EMERG Summary Dinner

Abstracts for potential presentations can be forwarded to the EMERG ecr steering group.


Registration has now closed.


The conference will take place on the Wellcome Genome Campus at Hinxton Hall, near Cambridgeshire. Hinxton Hall

Hinxton Hall Conference Centre is located on the Wellcome Genome Campus, alongside research institutions that are at the forefront of the genomics revolution. Hinxton Hall Conference Centre blends stunning contemporary architecture with state-of-the-art facilities, alongside a Grade II* listed country house, all set within a beautiful, rural 100 acre estate bordering the River Cam.

This location is near to Cambridge as well as a short drive from London Stansted airport.
There is also a direct link to London Stansted from central London.
This venue offers a number of advantages for assisting in our objectives of building collaboration and expanding knowledge.